Companies/US/APGE

APOGEE THERAPEUTICS, INC.

Last · NASDAQ$135.070.00 (0.00%)stale · yahoo · 1023h ago
Vol 143.8K ≈ 19.43M
Market cap$10.22B62.2M sh
P/E · TTM-31.1fwd -26.0 · eps -4.34 · loss
Beta0.33vs S&P 500
Div yield—annual · TTM
52w range
$35.39$135.09
Volume—session

Issuer

Legal nameAPOGEE THERAPEUTICS, INC.
HQUnited States (US)
ListingUS APGE
ISINUS03770N1019
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001974640
CIK0001974640
LinkedIn
Employees261
AddressApogee Therapeutics, Inc. 221 Crescent Street 02453, Waltham
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-03-02

From latest 10-K · 2026-03-02

  • Operating Cf Burn
  • Cash Runway Low

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Cash Runway Low — Cash runway ~0.6 years

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$1.25
Est. revenue
0

Press & signals

1 recent
  • GlobeNewswire

    Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Documents

FormReporting forFiledFlags
2026-09-032026-09-030
2026-09-032026-09-030
2026-09-032026-09-030
2026-09-032026-09-030